Discovery and Characterization of a Novel Aryl Hydrocarbon Receptor Inhibitor, IK-175, and Its Inhibitory Activity on Tumor Immune Suppression

Overview of attention for article published in Molecular Cancer Therapeutics, June 2022

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Above-average Attention Score compared to outputs of the same age and source (56th percentile)

Mentioned by

twitter: 7 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 14 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 10 X posts from 7 X users, with an upper bound of 17,557 followers.

RT @PatientPersists: "Increased levels of kynurenine, IDO1 or TDO2 and activated AHR are associated with immunosuppression and correlate wi…

11 Aug 2023

Reply Repost Favourite

"Increased levels of kynurenine, IDO1 or TDO2 and activated AHR are associated with immunosuppression and correlate with poor overall prognosis in multiple cancers" https://t.co/W6MKkICpWT

10 Aug 2023

Reply Repost Favourite

#ICYMI: MCT First Disclosure: Discovery and Characterization of a Novel Aryl Hydrocarbon Receptor Inhibitor, IK-175, and Its Inhibitory Activity on Tumor Immune Suppression. https://t.co/NEOnPKZjqS https://t.co/Pk39gQlPxx

08 Aug 2022

Reply Repost Favourite

RT @IkenaOncology: Our recent IK-175 publication, featured on the cover of @AACR Journal - Molecular Cancer Therapeutics (@MCT_AACR), highl…

03 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 6 additional X posts.